NAPIGEN INC

Agritech · Still private

Gene-edited rice plants with herbicide resistance traits in the mitochondrial genome to prevent pollen-mediated resistance transmission to weeds

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Agritech
Total capital
$500K
Federal grants
$500K
3 awards · 2020–2024
Rank in peer group#2 of 36
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
16 pending · first 2024
Rank in peer group#3 of 36

Capital timeline

20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $500K$100K$225K$175K
20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $500K$100K$225K$175K

Latest events

  • Federal grantAgriculture · **awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** The Goal Of This Project Is To Produce Rice Plants With Stable And Long-lived Herbicide Resistance Traits. Weeds Can Gain Herbicide Resistance By Receiving Pollen From Crop Plants And Acquiring Resistance Genes Directly. Such Weeds Are Tremendous Problems, Especially For Rice Farmers In The Southern US States As Well As In Asia, La$175K
  • Federal grantHealth and Human S · Phase I · New Transformation Technology for Gene Editing of Human Mitochondrial DNA Associated With Mitochondrial Diseases$225K
  • Federal grantAgriculture · Development Of Mitochondrial Transformation In Plants Toward Creating Elite Hybrid Wheat$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Agritech · Molecule

  • Federal grants#2 · top 6%
  • Granted patents#3 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 18
  • PendingHerbicide-resistant Genes For Mitochondrial TransformationUSPTOApplication 19317310
  • PendingOrganelle Genome Modification Using Polynucleotide Guided EndonucleaseUSPTOApplication 18936230
  • PendingPhosphite Dehydrogenase As A Selectable Marker For Mitochondrial TransformationUSPTOApplication 18716877
Show all 18 patent records
  • Herbicide-resistant Genes For Mitochondrial TransformationApr 23, 2026 · Application 19317310Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseMay 1, 2025 · Application 18936230Pending
  • Phosphite Dehydrogenase As A Selectable Marker For Mitochondrial TransformationJan 23, 2025 · Application 18716877Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseDec 24, 2024 · US 12,173,295Granted
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseMar 5, 2024 · US 11,920,140Granted
  • Phosphite Dehydrogenase As A Selectable Marker For Mitochondrial TransformationJun 8, 2023 · Application 18075874Pending
  • Organelle Genome ModificationNov 24, 2022 · Application 17561291Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseFeb 25, 2021 · Application 16641073Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseMay 9, 2019 · Application 16109523Pending
  • Herbicide-resistant Genes For Mitochondrial TransformationApplication PCTUS2024019118Pending
  • Phosphite Dehydrogenase As A Selectable Marker For Mitochondrial TransformationApplication 63286398Pending
  • Organelle Genome ModificationApplication PCTUS2020040730Pending
  • Organelle Genome ModificationApplication 62899495Pending
  • Organelle Genome ModificationApplication 62870441Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseApplication PCTUS2018047566Pending
  • Phosphite Dehydrogenase As A Selectable Marker For Mitochondrial TransformationApplication PCTUS2022080942Pending
  • Organelle Genome Modification Using Polynucleotide Guided EndonucleaseApplication 62548723Pending
  • Herbicide-resistant Acetolactate Synthase As A Selectable Marker For Mitochondrial TransformationApplication 63451173Pending

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .